Use of Rapid Antigen Tests during the Omicron Wave

Autor: Peter Jüni, Sarah Baert, Antoine Corbeil, Jennie Johnstone, Samir N. Patel, Pavlos Bobos, Upton Allen, Kali A. Barrett, Lisa L. Barrett, Nicolas S. Bodmer, Karen B. Born, Laura Bourns, Gerald A. Evans, Jessica Hopkins, Douglas G. Manuel, Andrew M. Morris, Fahad Razak, Beate Sander, Michelle Science, Robert Steiner, Joshua Tepper, Nisha Thampi, Allison McGeer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f8b20e3b63b6a6be48d4287cdc56cc01
https://doi.org/10.47326/ocsat.2022.03.56.1.0

Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated Vaccines

Autor: Anne Pham-Huy, Nicholas Carman, Otto G. Vanderkooi, Shelly A. McNeil, Lisa L. Barrett, John Marshall, Cynthia H. Seow, Eric I Benchimol, Talat Bessissow, Jennifer deBruyn, Jennifer Jones, Gil Y. Melmed, Matthew W Carroll, Frances Tse

Publikováno v: Journal of the Canadian Association of Gastroenterology

Background and Aims The effectiveness and safety of vaccinations can be altered by immunosuppressive therapies, and perhaps by inflammatory bowel disease (IBD) itself. These recommendations developed by the Canadian Association of Gastroenterology an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93351c27600389707ff9c7da5cd7cdf9
https://pubmed.ncbi.nlm.nih.gov/34334167

Directly Acting Triple Drug Anti-HCV Therapy Induces Sustained Virologic Response with a Six Week Regimen: A Proof of Concept Phase 2a Cohort Study

Autor: Gabbie Diaz, Phillip S. Pang, Eric G. Meissner, Eva Herrmann, David E. Kleiner, Colleen Kotb, Shyam Kottilil, Miriam M. Marti, Brad Wood, Jose Chavez, Gebeyehu Teferi, Zayani Sims, Michael A. Polis, Henry Masur, Michael A. Proschan, Richard Kwan, Amy Nelson, Rama Kapoor, Anthony S. Fauci, Stephen Abbott, G. Mani Subramanian, Michael C. Sneller, Emily E. Spurlin, Tess Petersen, D'Andrea Egerson, Anita Kohli, Chloe Gross, Kerry Townsend, A. Osinusi, Sreetha Sidharthan, William T. Symonds, Tim A. Jolley, Rachel Silk, John G. McHutchison, Lisa L Barrett, Dimitra Bon, Rohit Talwani

Summary Background Direct-acting antiviral drugs have a high cure rate and favourable tolerability for patients with hepatitis C virus (HCV). Shorter courses could improve affordability and adherence. Sofosbuvir and ledipasvir with ribavirin have hig

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86273f273c287ec38f8ae9055b43bdfa
https://europepmc.org/articles/PMC4427052/

Reply to Antinori and Bausch-Jurken.

Autor: d'Entremont-Harris M; Emerging and Re-Emerging Infections Team, Queen Elizabeth II Health Sciences Centre, Pharmacy Department, Nova Scotia Health., Ramsey TD; Emerging and Re-Emerging Infections Team, Queen Elizabeth II Health Sciences Centre, Pharmacy Department, Nova Scotia Health.; College of Pharmacy, Faculty of Health, Dalhousie University., Pelletier É; Emerging and Re-Emerging Infections Team, Queen Elizabeth II Health Sciences Centre, Pharmacy Department, Nova Scotia Health., Goodall B; Division of Infectious Diseases, Department of Medicine, Nova Scotia Health-Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, Nova Scotia, Canada., Barrett L; Division of Infectious Diseases, Department of Medicine, Nova Scotia Health-Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, Nova Scotia, Canada.

Publikováno v: The Journal of infectious diseases [J Infect Dis] 2024 Aug 16; Vol. 230 (2), pp. 524-526.

Dynamics of virological and immunological markers of HIV persistence after allogeneic haematopoietic stem-cell transplantation in the IciStem cohort: a prospective observational cohort study.

Autor: Salgado M; IrsiCaixa, Badalona, Spain; Germans Trias i Pujol Research Institute, Badalona, Spain; Centro de Investigación Biomédica en Red en Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain. Electronic address: msalgado@irsicaixa.es., Gálvez C; IrsiCaixa, Badalona, Spain., Nijhuis M; Translational Virology, Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, Netherlands; HIV Pathogenesis Research Unit, University of the Witwatersrand, Johannesburg, South Africa., Kwon M; Department of Hematology, Hospital Universitario Gregorio Marañón, Institute of Health Research Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Cardozo-Ojeda EF; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Xencor, Pasadena, CA, USA., Badiola J; University Hospital Virgen de las Nieves, Granada, Spain., Gorman MJ; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA, USA; Moderna Therapeutics, Cambridge, MA, USA., Huyveneers LEP; Translational Virology, Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, Netherlands., Urrea V; IrsiCaixa, Badalona, Spain., Bandera A; Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy., Jensen BO; Department of Gastroenterology, Hepatology, and Infectious Diseases, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University, Düsseldorf, Germany., Vandekerckhove L; HIV Cure Research Center, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent University, Ghent, Belgium., Jurado M; University Hospital Virgen de las Nieves, Granada, Spain., Raj K; Kings College Hospital, London, UK., Schulze Zur Wiesch J; Infectious Diseases Unit, Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; German Center for Infection Research, Partner Site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany., Bailén R; Department of Hematology, Hospital Universitario Gregorio Marañón, Institute of Health Research Gregorio Marañón, Madrid, Spain., Eberhard JM; Infectious Diseases Unit, Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; German Center for Infection Research, Partner Site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany; Helmholtz Institute for One Health, Greifswald, Germany., Nabergoj M; Division of Hematology, Hôpitaux Universitaires de Genève, Geneva, Switzerland; Hematology Service, Institut Central des Hôpitaux, Sion, Switzerland., Hütter G; DKMS Collection Center, Dresden, Germany., Saldaña-Moreno R; Hospital General de Jerez de la Frontera, Cádiz, Spain., Oldford S; Nova Scotia Health, Dalhousie University, Halifax, NS, Canada., Barrett L; Nova Scotia Health, Dalhousie University, Halifax, NS, Canada., Ramirez MLM; Centro de Investigación Biomédica en Red en Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain; University Hospital La Paz, IdiPAZ, Madrid, Spain., Garba S; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Merck, Rahway, NJ, USA., Gupta RK; Department of Medicine, University of Cambridge, Cambridge, UK., Revollo B; Department of Infectious Diseases, University Hospital Germans Trias i Pujol, Institut Català d'Oncologia, Badalona, Spain., Ferra-Coll C; Department of Hematology, University Hospital Germans Trias i Pujol, Institut Català d'Oncologia, Badalona, Spain; University of Vic-Central University of Catalonia, Vic, Spain., Kuball J; Department of Hematology and Center for Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands., Alter G; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA, USA; Moderna Therapeutics, Cambridge, MA, USA., Sáez-Cirión A; Viral Reservoirs and Immune Control Unit, Institut Pasteur, Université Paris Cité, Paris, France., Diez-Martin JL; Department of Hematology, Hospital Universitario Gregorio Marañón, Institute of Health Research Gregorio Marañón, Madrid, Spain., Duke ER; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Medicine, Allergy and Infectious Diseases Division, University of Washington, WA, Seattle, USA., Schiffer JT; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Medicine, Allergy and Infectious Diseases Division, University of Washington, WA, Seattle, USA., Wensing A; Translational Virology, Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, Netherlands; Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Martinez-Picado J; IrsiCaixa, Badalona, Spain; Germans Trias i Pujol Research Institute, Badalona, Spain; Centro de Investigación Biomédica en Red en Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain; University of Vic-Central University of Catalonia, Vic, Spain; Catalan Institution for Research and Advanced Studies, Barcelona, Spain. Electronic address: jmpicado@irsicaixa.es.

Publikováno v: The lancet. HIV [Lancet HIV] 2024 Jun; Vol. 11 (6), pp. e389-e405.